Innovation

ePiggyBac: A Novel Tool For Reprogramming Human Cells

The Rockefeller University
posted on 01/26/2010

Human embryonic stem cells (hESCs) hold immense potential for regenerative medicine, drug screens and basic research for human diseases. The ability to fully tap into the therapeutic potential of hESCs is limited by several factors, including difficulties in generating transgenic hESC lines, lack of reliable reporter systems for gain or loss of function. The present gene targeting techniques for hESCs are often limited to small cargo size and one expression cassette per insertion. These existing systems result in the stable integration of transfer vectors with hESCs, resulting in exogenous inserts in the genome and irreversible genome modifications, which in turn may lead to higher predisposition towards tumorigenesis or uncontrolled cell behavior. To overcome these limitations, our scientists have developed an ePiggyBac system, by engineering PiggyBac transposons. This system is capable of effectively delivering multigene inserts in hESCs in a reversible manner. In addition, it is also able to carry insulators, inducible expression cassettes, and short hairpin RNAs for gain- and loss- of-function approaches. Hence, the ePiggyBac is a powerful research tool for the stem cell field, and can be used to develop clinical-grade pluripotent cell lines.

Suggested Uses

Research tool for basic research, drug discovery and development

Advantages

•Can deliver inserts up to 18Kb • Show transgenesis efficiency of ~ 90%, which can be reversed.

Innovation Details
 

File Number: RU 878 

Other Information: -Lacoste, et al. (2009), Cell Stem Cell: 5, 332-342. -Patent pending


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact Nidhi Sabharwal at The Rockefeller University for more information.

Request more info via email request more info
People

Case Manager:

Nidhi Sabharwal Nidhi Sabharwal

Innovations (0)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Communities
Profile
Related Tags

Find more innovations


February 11, 2009

8,805 members 16,684 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...